Correlation Between Eyenovia and Day One
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Eyenovia and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Day One.
Diversification Opportunities for Eyenovia and Day One
Very weak diversification
The 3 months correlation between Eyenovia and Day is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Eyenovia i.e., Eyenovia and Day One go up and down completely randomly.
Pair Corralation between Eyenovia and Day One
Given the investment horizon of 90 days Eyenovia is expected to under-perform the Day One. In addition to that, Eyenovia is 6.63 times more volatile than Day One Biopharmaceuticals. It trades about -0.25 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 1,447 in Day One Biopharmaceuticals on August 31, 2024 and sell it today you would lose (75.00) from holding Day One Biopharmaceuticals or give up 5.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eyenovia vs. Day One Biopharmaceuticals
Performance |
| Timeline |
| Eyenovia |
| Day One Biopharmaceu |
Eyenovia and Day One Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eyenovia and Day One
The main advantage of trading using opposite Eyenovia and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.| Eyenovia vs. Reviva Pharmaceuticals Holdings | Eyenovia vs. Cidara Therapeutics | Eyenovia vs. Fortress Biotech | Eyenovia vs. Reviva Pharmaceuticals Holdings |
| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |